Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
TNYA | Tenaya Therapeutics, Inc. | Chief Fin. and Bus. Officer | $590K | -$30.5K | -4.91% | Feb 23, 2024 |
ELYM | Eliem Therapeutics, Inc. | Director | May 19, 2022 | |||
NKTX | Nkarta, Inc. | Director | Jun 13, 2024 | |||
ZYME | Zymeworks Inc. | EVP, Chief Bus & Fin Officer | Sep 1, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|